2Nd Gen Centrimag Primary Console
Device Heart failure
PDI 07640135140702
General payments
$237,113
Research payments
$311,369
Through program year 2024, $237,113 in general payments and $311,369 in research payments were reported against 2Nd Gen Centrimag Primary Console (Heart failure).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $67,514 | 683 |
| 2024 | Research | $81,296 | 38 |
| 2023 | General | $58,144 | 632 |
| 2023 | Research | $89,744 | 37 |
| 2022 | General | $111,454 | 914 |
| 2022 | Research | $140,330 | 78 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 54 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
2,229 general · 153 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.